
Jasmohan Bajaj, MD, MS, joins Nancy Reau, MD, and Kimberly Brown, MD, on who to screen for HE in clinic and how to prepare patients and families.
The Q2 recap for hepatology spotlights regulatory approvals, clinical trial updates, and the launch of HCPLive’s flagship hepatology podcast.
The second quarter of 2025 delivered a wave of meaningful developments in hepatology—from FDA approvals that expand therapeutic options to promising pipeline data that could shape the future of care across a spectrum of liver diseases and the launch of a new hepatology podcast hosted by some of the field’s leading experts.






